ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 5

Rheumatoid Arthritis and Periodontitis: Association and Characteristics of Chronic Periodontitis

BEATRIZ RODRIGUEZ-LOZANO1, Jerián González Febles2, Jorge Luis Garnier Rodríguez3, Shashi Dadlani4, Elisa Trujillo-Martin1, Vanesa Hernández Hernández1, Sagrario Bustabad5, Mariano Sanz Alonso2 and Federico Díaz-González1, 1Rheumatology, Hospital Universitario de Canarias, S/C Tenerife, Spain, 2Periodontology, Universidad Complutense de Madrid, Madrid, Spain, 3Odontology, Dental Clinic Garnier, S/C Tenerife, Spain, 4Periodontology, Dental Clinic Garnier, S/C Tenerife, Spain, 5Rheumatology, Hospital Universitario de Canarias, La Laguna, Tenerife, Spain

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Periodontitis and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Epidemiology and Public Health - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Recent clinical-epidemiological data suggest that periodontitis (P) shows higher prevalence in rheumatoid arthritis (RA) patients. However, due to the scarcity of epidemiological studies, the strength of association is limited, with odds ratios (OR) ranging from 1.82-8.05. The prevalence of P in the adult Spanish population1 varies from 16 -30%,with a lower prevalence of severe P (5-11%). Nevertheless, the prevalence of P in Spanish RA patients is unknown. Our purpose is: 1.To determine the prevalence of P and its association in RA patients in our reference area.2.To describe the characteristics of P in RA patients.

Methods: Observational, descriptive, cross-sectional, case-control study of RA patients > 18 years old (ACR/EULAR 2010) in a hospital Rheumatology Department, and a control group with non-inflammatory joint disease, who had at least 4 teeth, had not received dental prophylaxis or antibiotics 6 months before the study. Socio-demographic and anthropometric variables included were body mass index, smoking status, Graffar scale, stress level, annual dental prophylaxis, and co-morbidities such as osteoporosis (OP), diabetes mellitus (DM), dyslipidemia (DS), arterial hypertension, ischemic cardiovascular disease (ICD). Periodontal Variables: plaque index (PI), bleeding on probing (BoP), probing pocket depth (PPD), recession (REC), clinical attachment level (CAL). The dental team: 2 periodontists, 2 general dentists and 1 dental hygienist with inter-observer variability<30%. Full mouth CAL, PPD and periapical x-rays were taken. CAL was classified according to the European Workshop in 2005 (Tonetti),into level 0 (absence), TL1 (mild), TL2 (severe).Statistical analysis with Stata 13.1 using Student´s t test , Kruskal Wallis and Chi-square test.

Results: 344 patients were included: 187 RA (147 F/40 M) and 157 controls (101F/56M). The two groups were similar in age 54.9 (17.9), BMI 27.8 (4.6), stress level, DM and ICD and different in gender (>nº of males in controls), socioeconomic status (lower level in RA patients), > nº of current and former smokers in the RA group (19.25%vs 8.92%/ 24.6%vs 11.46%),OP (23.45% RA vs 7.8%), DS (hypertriglyceridemia ) 11.23% RA vs 4.46% in controls. 182/187 RA patients had P (97. 33%) vs 104/157 (66.24%) with P in controls. Regarding severity P: TL1 in 52.41% RA vs 54.14%;TL2 in 44.92% RA patients vs 12.1% in controls (p<0.001), OR 18.55 (CI 95% 7.18-47.87),which was maintained after adjusting for confounders: OR 16.25 + 9.29 (95% CI 5.23 – 49.86). Moreover, RA patients had poor periodontal status with a dramatic increase in all periodontal parameters: PI, PPD, nº and percentage of PPD ≥5mm and BoP (p<0.001) compared with the control group.

Conclusion: 1.Our study showed a strong association between RA and periodontitis with an adjusted OR 16.25. 2. The prevalence of severe periodontitis was significantly greater in RA patients than controls or the general population. 3. There were no differences in the prevalence of mild periodontitis between groups. 4. With respect to severity, RA patients showed more severe periodontitis than controls.     References: 1Bravo-Pérez M C-PE. Encuesta de salud oral en España 2005.RCOE.11(4):409-56.


Disclosure: B. RODRIGUEZ-LOZANO, None; J. González Febles, None; J. L. Garnier Rodríguez, None; S. Dadlani, None; E. Trujillo-Martin, None; V. Hernández Hernández, None; S. Bustabad, None; M. Sanz Alonso, None; F. Díaz-González, None.

To cite this abstract in AMA style:

RODRIGUEZ-LOZANO B, González Febles J, Garnier Rodríguez JL, Dadlani S, Trujillo-Martin E, Hernández Hernández V, Bustabad S, Sanz Alonso M, Díaz-González F. Rheumatoid Arthritis and Periodontitis: Association and Characteristics of Chronic Periodontitis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/rheumatoid-arthritis-and-periodontitis-association-and-characteristics-of-chronic-periodontitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatoid-arthritis-and-periodontitis-association-and-characteristics-of-chronic-periodontitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology